✓ Last verified: April 23, 2026 — Edited & verified by Angelica Bottaro for HealingMaps Editorial Staff

Known For: Integrative psychiatry clinic combining ketamine therapy with Stellate Ganglion Block, counseling, and brain rehabilitation
| Review Scores | Google: N/A · Strong patient testimonials |
| Location | Scottsdale, Arizona |
| Address | 8090 85th Way, #100, Scottsdale, AZ 85258 |
| Phone | (866) 999-1177 |
| Website | neuregen.com |
| Treatments | IV Ketamine, Stellate Ganglion Block (SGB), Psychiatry, Counseling |
| Conditions Treated | Depression, Anxiety, PTSD, Chronic Stress |
| Cost | N/A — contact clinic |
| Insurance | N/A — contact clinic |
| KAP Available? | Yes — individual, couples, and group therapy settings |
| Clinical Lead | Dr. David George — Integrative Psychiatrist |
HealingMaps Take: Neuregen offers one of the most comprehensive treatment menus in the Scottsdale area — pairing ketamine with SGB, hypnotherapy, and psychiatric care under Dr. George. The KAP options (individual, couples, group) are a standout for those wanting therapy-integrated ketamine.
Market Position: Neuregen offers the full ketamine-assisted psychotherapy (KAP) protocol alongside medical-only ketamine dosing — one of the more integrated treatment menus in the Scottsdale metro.
Industry pricing reference. Neuregen has not published specific per-session pricing — contact the clinic directly for a quote. The calculator above shows typical metro-level cost estimates across protocols, not this clinic’s specific prices.
| Protocol | Typical Industry Cost | Offered Here |
|---|---|---|
| IV Ketamine | $350–$650/session | ✓ Yes |
| Spravato (esketamine) | $0–$250 copay (insured) | — |
| IM Ketamine | $250–$400/injection | — |
| KAP (with therapist) | $400–$1,200/session | ✓ Yes |
| At-home troches | $150–$300/month | — |
Sources: CDC PLACES 2023 (Maricopa County, AZ, crude prevalence) · U.S. Census ACS 5 Year · HealingMaps proprietary patient inquiry data.
Behind this data: HealingMaps has analyzed 23,496 patient inquiries (Oct 2022 – Mar 2026), mapped 1,473 verified clinics across 3,142 counties, scraped 132 clinic pricing pages, and collected 658 practitioner survey responses. This snapshot reflects our multi-source methodology.
The U.S. ketamine therapy market is $3.4 billion today and projected to reach $6.9 billion by 2030 — more than doubling in a six-year window as access and awareness expand. Source: HealingMaps 2026 Ketamine Clinic Intelligence Report — drawn from 23,496 patient inquiries and 132 clinic website analyses.
This 3-question summary is matched to the protocols and conditions Neuregen treats. Editorial responses are HealingMaps-authored, grounded in our 2026 Ketamine Clinic Intelligence Report.
Neuregen treats depression via IV ketamine (off-label, evidence-based). Insurance coverage is rare for IV/KAP — most patients pay out of pocket. TRD is typically defined as two or more prior antidepressant trials without sufficient response — patients meeting that bar are best candidates here.
Yes — Neuregen treats PTSD. Ketamine for trauma differs from depression treatment: dosing is often lower per session, and pairing the protocol with trauma-focused therapy between sessions is common. A reasonable consult question: whether PTSD patients here typically use ketamine alone or alongside an outside therapist.
Yes — Neuregen treats anxiety, including generalized anxiety, social anxiety, and panic disorder. The evidence base for ketamine in anxiety is less robust than for depression, but it can be a meaningful option for patients who haven’t responded to SSRIs or benzodiazepines. Worth asking which of their protocols they typically recommend for anxiety-primary patients.
Learn more about this treatment:
Leave a Reply